Blake, S.; Baroni, L.; Piboolnurak, P.; Harding, T.; Harding, M.; Blake, C.
Reducing Neuroinflammation and Risk of Mild Cognitive Impairment and Alzheimer’s Disease by Reducing Dietary Lipopolysaccharides, Arachidonic Acid, and Advanced Glycation End Products. J. Dement. Alzheimer's Dis. 2025, 2, 27.
https://doi.org/10.3390/jdad2030027
AMA Style
Blake S, Baroni L, Piboolnurak P, Harding T, Harding M, Blake C.
Reducing Neuroinflammation and Risk of Mild Cognitive Impairment and Alzheimer’s Disease by Reducing Dietary Lipopolysaccharides, Arachidonic Acid, and Advanced Glycation End Products. Journal of Dementia and Alzheimer's Disease. 2025; 2(3):27.
https://doi.org/10.3390/jdad2030027
Chicago/Turabian Style
Blake, Steven, Luciana Baroni, Panida Piboolnurak, Thomas Harding, Maile Harding, and Catherine Blake.
2025. "Reducing Neuroinflammation and Risk of Mild Cognitive Impairment and Alzheimer’s Disease by Reducing Dietary Lipopolysaccharides, Arachidonic Acid, and Advanced Glycation End Products" Journal of Dementia and Alzheimer's Disease 2, no. 3: 27.
https://doi.org/10.3390/jdad2030027
APA Style
Blake, S., Baroni, L., Piboolnurak, P., Harding, T., Harding, M., & Blake, C.
(2025). Reducing Neuroinflammation and Risk of Mild Cognitive Impairment and Alzheimer’s Disease by Reducing Dietary Lipopolysaccharides, Arachidonic Acid, and Advanced Glycation End Products. Journal of Dementia and Alzheimer's Disease, 2(3), 27.
https://doi.org/10.3390/jdad2030027
